StonvexLoading…
StonvexCore line items from GVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.42B | $4.01B | $3.51B | $3.30B |
Operating Income | $282.45M | $207.36M | $80.06M | $85.38M |
Net Income | $193.00M | $126.35M | $43.60M | $83.30M |
EPS (Diluted) | $3.86 | $2.62 | $0.97 | $1.70 |
Total Assets | $4.03B | $3.03B | $2.81B | $2.17B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $529.22M | $578.33M | $417.66M | $293.99M |
Free Cash Flow OCF − CapEx | $330.65M | $319.94M | $43.32M | $-65.97M |
Shares Outstanding | 43.50M | 43.42M | 43.94M | 43.74M |